CODEX DNA INC (DNAY) Forecast, Price Target & Analyst Ratings
NASDAQ:DNAY • US1920031010
1.3 USD
+0.1 (+8.33%)
Last: Jan 3, 2023, 08:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CODEX DNA INC (DNAY).
Forecast Snapshot
Consensus Price Target
$6.63
+ 410.00% Upside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2022
EPS Estimate-$0.47
Revenue Estimate6.426M
ChartMill Buy Consensus
84.44%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$6.63
Upside
+ 410.00%
From current price of $1.30 to mean target of $6.63, Based on 9 analyst forecasts
Low
$5.05
Median
$6.63
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
N/A
Price Target Summary
9 analysts have analysed DNAY and the average price target is 6.63 USD. This implies a price increase of 410% is expected in the next year compared to the current price of 1.3.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
DNAY was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about DNAY.
In the previous month the buy percentage consensus was at a similar level.
DNAY was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-09 | Keybanc | Maintains | Overweight |
| 2021-07-13 | Keybanc | Initiate | Overweight |
| 2021-07-13 | Cowen & Co. | Initiate | Outperform |
| 2021-07-13 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2022
EPS Estimate-$0.47
Revenue Estimate6.426M
Revenue Q2Q108.77%
EPS Q2Q-9.12%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.805M | 6.576M 36.86% | 11.043M 67.93% | 24.735M 123.99% | 47.022M 90.10% | 76.041M 61.71% | 116.99M 53.85% | 150.29M 28.46% | |
| EBITDA YoY % growth | -6.119M | -15.495M -153.23% | -34.466M -122.43% | -50.235M -45.75% | -52.224M -3.96% | -48.909M 6.35% | -43.544M 10.97% | -49.898M -14.59% | |
| EBIT YoY % growth | -6.976M | -16.361M -134.53% | -35.374M -116.21% | -53.142M -50.23% | -56.457M -6.24% | -55.08M 2.44% | -48.488M 11.97% | -53.373M -10.07% | |
| Operating Margin | -145.18% | -248.80% | -320.33% | -214.85% | -120.07% | -72.43% | -41.45% | -35.51% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.87 -6.40% | -1.57 16.12% | -1.30 16.94% | -1.49 -14.24% | -1.73 -16.53% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.47 -9.12% | -0.31 32.00% | -0.28 44.92% | -0.30 29.57% | -0.38 19.57% |
| Revenue Q2Q % growth | 6.426M 108.77% | 7.344M 30.31% | 7.956M 40.69% | 8.874M 32.94% | 11.016M 71.43% |
| EBITDA Q2Q % growth | -12.954M -15.77% | -7.956M 36.52% | -9.078M 34.13% | -10.098M -0.06% | -12.852M 0.79% |
| EBIT Q2Q % growth | -13.821M -14.25% | -9.18M 28.63% | -10.098M 30.30% | -11.118M 1.18% | -13.872M -0.37% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.97%
EPS Next 5 Year
0.26%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
85.04%
Revenue Next 5 Year
65.78%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-12.51%
EBIT Next 5 Year
-7.76%
CODEX DNA INC / DNAY Forecast FAQ
What is the average price target for CODEX DNA INC (DNAY) stock?
9 analysts have analysed DNAY and the average price target is 6.63 USD. This implies a price increase of 410% is expected in the next year compared to the current price of 1.3.
What are the consensus estimates for CODEX DNA INC (DNAY) next earnings?
The consensus EPS estimate for the next earnings of CODEX DNA INC (DNAY) is -0.47 USD and the consensus revenue estimate is 6.43M USD.
How do analysts rate CODEX DNA INC (DNAY)?
The consensus rating for CODEX DNA INC (DNAY) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.